Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma.

Marengo, Barbara; Meta, Elda; Brullo, Chiara; Ciucis, Chiara De; Colla, Renata; Speciale, Andrea; Garbarino, Ombretta; Bruno, Olga; Domenicotti, Cinzia

Marengo, Barbara; Meta, Elda; Brullo, Chiara; Ciucis, Chiara De; Colla, Renata; Speciale, Andrea; Garbarino, Ombretta; Bruno, Olga; Domenicotti, Cinzia.

Afiliación

Marengo B; Department of Experimental Medicine, General Pathology Section, University of Genoa, Genoa, Italy.
Meta E; Department of Pharmacy, Medicinal Chemistry Section, University of Genoa, Genoa, Italy.
Brullo C; Department of Oncology, Laboratory of Angiogenesis and Vascular Metabolism, Katholieke Universiteit Leuven, Leuven, Belgium.
Ciucis C; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.
Colla R; Department of Pharmacy, Medicinal Chemistry Section, University of Genoa, Genoa, Italy.
Speciale A; Department of Experimental Medicine, General Pathology Section, University of Genoa, Genoa, Italy.
Garbarino O; Department of Experimental Medicine, General Pathology Section, University of Genoa, Genoa, Italy.
Bruno O; UOC Mutagenesis and Cancer Prevention, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Domenicotti C; Department of Experimental Medicine, General Pathology Section, University of Genoa, Genoa, Italy.

Oncotarget ; 14: 129-130, 2023 Feb 11.

Article en En | MEDLINE | ID: mdl-36780313

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google